To read the full story, subscribe or sign in.

Further evidence presented at ongoing meeting supporting utility of (-)-OSU-6162 in PD

June 14, 2000

BioWorld Science Conferences Neurology/psychiatric

Today's news in brief

BioWorld

BioWorld briefs for May 15, 2026.

Illustration of a glowing circle to represent circRNA

ASGCT 2026: Circular RNA, the new beast in gene and cell therapy

BioWorld

Circular RNA (circRNA) is not a new concept, but it is a novel strategy in the field of gene and cell therapy. While mRNA vaccines have revolutionized medicine,...

Advancing the 'best of both' – BMS, Hengrui enter $15.2B deal

BioWorld

In a deal potentially worth up to $15.2 billion, Jiangsu Hengrui Pharmaceuticals Co. Ltd. is joining efforts with Bristol Myers Squibb Co. to advance 13 early...

News in brief

BioWorld Asia

BioWorld Asia briefs for May 12, 2026

3D illustration of adeno-associated viruses

ASGCT 2026: Uncovering the mechanisms of AAV toxicity

BioWorld

Gene therapies rely on vectors to reach the target tissue where they act, such as adeno-associated viruses (AAVs) or lipid nanoparticles (LNPs), among other...